Plasma biomarker tool for the diagnosis of liver cancer comprising liver carboxylesterase 1 and liver cancer screening method

• 1. 一种包括肝羧酸酯酶1的用于诊断肝癌的血浆生物标记物工具及肝癌筛选方法 [P] . 中国专利： CN102027127B . 2017.03.29
• 2. 一种包括肝羧酸酯酶1的用于诊断肝癌的血浆生物标记物工具及肝癌筛选方法 [P] . 中国专利： CN102027127A . 2011-04-20
• 3. PLASMA BIOMARKER TOOL FOR DIAGNOSIS OF LIVER CANCER COMPRISING LIVER CARBOXYLESTERASE 1 AND LIVER CANCER SCREENING METHOD [P] . 日本专利： JP2014197021A . 2014-10-16

  机译： 用于诊断包括肝羧化酶1的肝癌的血浆生物标志物工具和肝癌筛查方法

• 4. Plasma biomarker tool for the diagnosis of liver cancer comprising liver carboxylesterase 1 and liver cancer screening method [P] . 美国专利： US8198038B2 . 2012-06-12

  机译： 包括肝羧酸酯酶1的用于肝癌诊断的血浆生物标志物工具和肝癌筛查方法

• 5. PLASMA BIOMARKER TOOL FOR THE DIAGNOSIS OF LIVER CANCER COMPRISING LIVER CARBOXYLESTERASE 1 AND LIVER CANCER SCREENING METHOD [P] . 美国专利： US2011097738A1 . 2011-04-28

  机译： 用于诊断包括肝羧化酶1的肝癌的血浆生物标志物工具和肝癌筛查方法

• 1. A study protocol of population-based cancer screening cohort study on esophageal, stomach and liver cancer in rural China [J] . Jiang Li, He Li, Hongmei Zeng, 中国癌症研究（英文版） . 2020,第004期
• 2. Investigation of Plasma cell‐free cancer genome chromosomal instability as a tool for targeted minimally invasive biomarkers for primary liver cancer diagnoses [J] . Shuang Feng, Zhiwen Ding, Jin Wang, Cancer Medicine . 2020,第14期
• 3. Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool. [J] . Kaneda Y Expert opinion on drug delivery . 2010,第9期
• 4. Polyamine Metabolites Profiling for Characterization of Lung and Liver Cancer Using an LC-Tandem MS Method with Multiple Statistical Data Mining Strategies: Discovering Potential Cancer Biomarkers in Human Plasma and Urine [J] . Xu Huarong, Liu Ran, He Bosai, Molecules . 2016,第8期
• 5. UHPLC-QTOF Based Metabolomics for discovering Etiological Biomarkers of Liver Cancers Using Serum Samples from a Large Multinational Prospective Cohort [C] . Dinesh Barupal, Augustin Scalbert, Talita Duarte-Salles, International Mass Spectrometry Conference . 2014
• 6. A Cancer-targeting Liposomal Delivery System for Photodynamic Diagnosis and Therapy of Cancers in Peritoneal Cavity [D] . Luan, Shijie. 2020
• 7. Investigation of Plasma cell‐free cancer genome chromosomal instability as a tool for targeted minimally invasive biomarkers for primary liver cancer diagnoses [O] . Shuang Feng, Zhiwen Ding, Jin Wang, 2020
• 8. Polyamine Metabolites Profiling for Characterization of Lung and Liver Cancer Using an LC-Tandem MS Method with Multiple Statistical Data Mining Strategies: Discovering Potential Cancer Biomarkers in Human Plasma and Urine [O] . Huarong Xu, Ran Liu, Bosai He, 2016

• 1. Challenges of liver cancer:Future emerging tools in imaging and urinary biomarkers [J] . Francesca M Trovato ,Joshua M Tognarelli ,Mary ME Crossey . 世界肝病学杂志：英文版（电子版） . 2015,第26期
• 2. Screening of aptamers and their potential application in targeted diagnosis and therapy of liver cancer [J] . Guo-Qing Zhang ,Li-Ping Zhong ,Nuo Yang . 世界胃肠病学杂志：英文版 . 2019,第26期
• 3. Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers [J] . Dong-Xing Cao ,Zhi-Jie Li ,Xiao-Ou Jiang . 世界胃肠病学杂志：英文版 . 2012,第30期
• 4. The re-emergence of the GP73 and fucosylated liver cancer biomarkers [J] . Block Timothy . 中国工程科学 . 2014,第004期
• 5. microRNA作为生物标志物在肝癌诊断中的应用 [C] . 万睿 . 第十届全国肝脏疾病临床学术大会 . 2016
• 6. 血浆microRNA-224用于肝癌诊断和预后标志物研究 [A] . 高军平 . 2012